title: Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
abstract: The prognosis of colorectal cancer has not significantly changed during the last 30 years. While evaluation of tumour cell proliferation may provide prognostic information, results obtained so far have been contradictory Heterogeneity in tumour cell proliferation may explain these contradictions. With in vivo injection of iododeoxyuridine (IdUrd), estimation of labelling index (LI), S-phase transit time (Ts) and potential doubling time (Tpot) may be performed from a single sample. A total of 109 colorectal cancers were studied after in vivo injection of IdUrd before surgical removal. From each cancer, four to eight samples were processed for both flow cytometrical (FCM) and immunohistochemical (IHC) visualization of IdUrd incorporation. LI/IHC was morphometrically quantified at both the luminal border and the invasive margin of these tumours. LI was significantly higher at the luminal border compared with the invasive margin, although they were correlated with each other. Using combined IHC and FCM methods, rapidly growing colorectal cancers (high LI and/or low Tpot) showed an increased survival (significant for LI at the invasive margin and for Tpot at both the invasive margin and the luminal border) in the entire unselected material and for radically removed Dukes' B tumours. FCM data alone did not discriminate for survival, with the exception of Ts in diploid and radically removed Dukes' B tumours.
authors.affiliation: Department of Pathology, Umeå University, Sweden.
authors.forename: R
authors.initials: R
authors.lastname: Palmqvist
authors.forename: A
authors.initials: A
authors.lastname: Oberg
authors.forename: C
authors.initials: C
authors.lastname: Bergström
authors.forename: J N
authors.initials: JN
authors.lastname: Rutegård
authors.forename: B
authors.initials: B
authors.lastname: Zackrisson
authors.forename: R
authors.initials: R
authors.lastname: Stenling
mesh_terms: D002430:Cecal Neoplasms / Q000473:pathology / Q000601:surgery; D002455:Cell Division; D003110:Colonic Neoplasms / Q000473:pathology / Q000601:surgery; D015179:Colorectal Neoplasms / Q000235:genetics / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D007065:Idoxuridine / Q000493:pharmacokinetics; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D008940:Mitotic Index; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011003:Ploidies; D011379:Prognosis; D012004:Rectal Neoplasms / Q000473:pathology / Q000601:surgery; D012044:Regression Analysis; D012811:Sigmoid Neoplasms / Q000473:pathology / Q000601:surgery; D018709:Statistics, Nonparametric; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007065:Idoxuridine